Public Market Listing
065660KOSDAQ
Live quotes, historical charts, and market capitalization for Anterogen are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
Cupistem / ALLO-ASC(Cupistem (autologous, approved in Korea)) | Phase 3 | Adipose-derived MSC therapyCell therapy | Inflammatory Bowel Disease Crohn's Disease |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.